The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,769.50
Bid: 1,770.00
Ask: 1,770.50
Change: 8.50 (0.48%)
Spread: 0.50 (0.028%)
Open: 1,770.00
High: 1,772.50
Low: 1,766.00
Prev. Close: 1,761.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London pre-open: Poor data out from Asia to push FTSE lower

Mon, 10th Mar 2014 07:16

- Asia stocks slump as Japanese, Chinese disappoint- BCC ups economic growth forecastsUK stocks will start the day in the red, dragged lower by the performance in Asia overnight, hit by both Chinese and Japanese data.City sources predict the FTSE 100 will open 21 points lower than Friday's close of 6,712.67.China reported an unexpected trade deficit for February after exports slumped 18.1%, fuelling concerns that the world's second-largest economy is suffering a serious slowdown. However, Capital Economics believes that the drop largely reflects seasonal factors such as the Chinese Lunar New Year holiday, during which many factories remained shut. Imports grew by a slightly stronger than forecast 10.1% during the same month. Be that as it may, the Shanghai stock exchange´s composite index was nearly 2.86% lower to 1,999.07 at 07:30. In Japan, the current account deficit hit a record 1.5trn yen (around £8.7bn) in January, which comes ahead of a planned tax increase on sales next month - a move that had been expected to prompt higher spending in the lead up to it. Meanwhile, the country's economic growth slowed to 0.7% in 2013, below estimates of 1%. BCC predicts Q2 growth to exceed early-2008 levels The British Chambers of Commerce (BCC) has forecast an increase in the size of the UK economy that will take it above the levels seen in early 2008.It predicted economic growth for the year would be 2.8%, 0.1% higher than its previous estimate.In this morning's company announcements, GlaxoSmithKline (GSK) revealed it has increased its stake in its pharmaceuticals subsidiary in India from 50.7% to 75% following an open offer. The group said the move would increase its exposure to a "strategically important market" and was a "significant vote of confidence in the future growth prospects" of the business. Manufacturing group Senior confirmed that it has entered into an agreement to buy Malaysian based UPECA Technologies for £75.5m in cash. The acquisition of UPECA Technologies, which provides manufacturing services for high precision metal machining, is expected to complete towards the end of March. Fruit supplier Fyffes served up sweeter annual profits and revenue, but said it was facing rising costs.APC Technology said it expects half-year sales to be 30% ahead of the prior year after the computer manufacturer took on new major customers. Sales in the first half of 2014 is anticipated to come in at £12.1m, up from £9.2m a year earlier. Pre-tax profit is projected to be £700,000, compared to £47,000 in 2012.Meanwhile, buy shares when Scholium, the rare book dealer, floats on the stock market, Midas advised in the Mail on Sunday. The business, owned by former Blackwell Publishing director Philip Blackwell, is selling shares at 100p each to raise £10m to buy more stock and to hold cash in reserve for when prized collections come to the market. The money will also be used to develop Scholium's art bookshop and high-end library-compiling business. Demand is growing from rich foreign buyers. Pre-tax profits are expected to more than double in coming year and a dividend is planned from 2015.NR
More News
Today 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.